PROTEIN KINASE INHIBITORS, ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
- BCR-ABL TYROSINE KINASE INHIBITORS
- EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) TYROSINE KINASE INHIBITORS
- B-RAF SERINE-THREONINE KINASE (BRAF) INHIBITORS
- ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS
- MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS
- CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS
- MAMMALIAN TARGET OF RAPAMYCIN (MTOR) KINASE INHIBITORS (L01EG)
- HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) TYROSINE KINASE INHIBITORS
- JANUS-ASSOCIATED KINASE (JAK) INHIBITORS (L01EJ)
- VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR (VEGFR) TYROSINE KINASE INHIBITORS
- BRUTON'S TYROSINE KINASE (BTK) INHIBITORS
- PHOSPHATIDYLINOSITOL-3-KINASE (PI3K) INHIBITORS
- FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) TYROSINE KINASE INHIBITORS
- OTHER PROTEIN KINASE INHIBITORS IN ATC
Using Health Canada Drug Database
updated on 15Nov2025.
This page last updated as per date shown above.